| Literature DB >> 32689631 |
Jia Xu1, Zhiling Yang2.
Abstract
BACKGROUND: Pneumonia is a major complication leading to death after stroke. The risk factors of pneumonia in convalescent patients who have experienced stroke remain poorly defined.Entities:
Keywords: Logistic regression; Pathogenic microorganism; Pneumonia; Rehabilitation; Risk factors; Stroke
Mesh:
Substances:
Year: 2020 PMID: 32689631 PMCID: PMC7221409 DOI: 10.1016/j.jstrokecerebrovasdis.2020.104955
Source DB: PubMed Journal: J Stroke Cerebrovasc Dis ISSN: 1052-3057 Impact factor: 2.136
Factors and assignments of pneumonia in convalescent patients with stroke.
| Factors | Subclass | Assignments |
|---|---|---|
| Gender | “1” for “male”; “0” for “female” | |
| Age≥60 | “1” for the presence; “0” for “none” | |
| Main diagnosis | “1” for “ischemic stroke”; “0” for “hemorrhagic stroke” | |
| Course of stroke | 1W-1M | “C1” for the presence |
| 1-2M | “C2” for the presence | |
| 2-3M | “C3” for the presence | |
| 3-4M | “C4” for the presence | |
| 4-5M | “C5” for the presence | |
| 5-6M | “C6” for the presence | |
| Barthel index scores | ≤40 | “B1” for the presence |
| 41-60 | “B2” for the presence | |
| 61-99 | “B3” for the presence | |
| 100 | “B4” for the presence | |
| Craniotomy surgery | “1” for the presence; “0” for “none” | |
| Diabetes | “1” for the presence; “0” for “none” | |
| Hypertension | “1” for the presence; “0” for “none” | |
| Basic lung diseases | “1” for the presence; “0” for “none” | |
| Feeding tube | “1” for the presence; “0” for “none” | |
| Trachea ventilation | “1” for the presence; “0” for “none” | |
| Drugs affect immunity | “1” for the presence; “0” for “none” | |
| Hypoproteinemia | “1” for the presence; “0” for “none” |
Barthel index scores: lower scores representing greater nursing dependency.
Basic lung diseases including chronic lung disease includes COPD, asthma, bronchiectasis, and interstitial lung disease.
Baseline characteristics of the patients.
| Factors | Subclass | Cases | Data missing/correction | Percentage (%) |
|---|---|---|---|---|
| Age≥60 | 195 | 0, | 51.32 | |
| Course of stroke | 1W-1M | 164 | 0, | 43.16 |
| 1-2M | 107 | 28.16 | ||
| 2-3M | 49 | 12.89 | ||
| 3-4M | 29 | 7.63 | ||
| 4-5M | 20 | 5.26 | ||
| 5-6M | 11 | 2.89 | ||
| Barthel index scores | ≤40 | 162 | 67, | 51.76 |
| 41-60 | 77 | 24.60 | ||
| 61-99 | 50 | 15.97 | ||
| 100 | 24 | 7.67 | ||
| Craniotomy surgery | 95 | 0, | 25.00 | |
| Diabetes | 101 | 0, | 26.58 | |
| Hypertension | 345 | 0, | 90.79 | |
| Basic lung diseases | 17 | 0, | 4.47 | |
| Feeding tube | 67 | 0, | 17.63 | |
| Trachea ventilation | 18 | 0, | 4.74 | |
| Drugs affect immunity | 10 | 5, | 2.67 | |
| Hypoproteinemia | 81 | 14, | 22.13 |
Logistic regression predicting likelihood of pneumonia based on 13 factors.
| Factors | B | S.E. | Wald | df | P | OR | 95%C.I. for OR | |
|---|---|---|---|---|---|---|---|---|
| Lower | Upper | |||||||
| Main diagnosis | 0.35 | 0.51 | 0.46 | 1 | 0.50 | 1.42 | 0.52 | 3.88 |
| Gender | 0.19 | 0.47 | 0.16 | 1 | 0.69 | 1.20 | 0.48 | 3.02 |
| Age≥60 | 0.06 | 0.48 | 0.01 | 1 | 0.90 | 1.06 | 0.42 | 2.69 |
| Course of stroke | 0.06 | 0.16 | 0.12 | 1 | 0.73 | 1.06 | 0.77 | 1.46 |
| Barthel index scores | 0.68 | 0.34 | 3.93 | 1 | 0.05 | 1.97 | 1.01 | 3.87 |
| Craniotomy surgery | 0.54 | 0.49 | 1.18 | 1 | 0.28 | 1.71 | 0.65 | 4.51 |
| Basic lung diseases | 1.45 | 0.73 | 3.96 | 1 | 0.05 | 4.24 | 1.02 | 17.61 |
| Trachea ventilation | 1.88 | 0.87 | 4.63 | 1 | 0.03 | 6.56 | 1.18 | 36.34 |
| Feeding tube | 1.80 | 0.43 | 17.23 | 1 | 0.00 | 6.06 | 2.59 | 14.18 |
| Hypertension | -0.94 | 0.64 | 2.15 | 1 | 0.14 | 0.39 | 0.11 | 1.37 |
| Diabetes | -0.38 | 0.53 | 0.52 | 1 | 0.47 | 0.68 | 0.24 | 1.92 |
| Hypoproteinemia | 1.38 | 0.48 | 8.33 | 1 | 0.00 | 3.97 | 1.56 | 10.10 |
| Drugs affect immunity | 0.62 | 0.91 | 0.47 | 1 | 0.49 | 1.86 | 0.31 | 11.02 |
| Constant | -12.46 | 3.53 | 12.43 | 1 | 0.00 | 0.00 | ||
Multinomial logistic regression to predict pneumonia in convalescent patients with stroke using the Barthel index.
| Pneumonia |or not | B | S.E. | Wald | df | Sig. | OR | 95% Confidence Interval for OR | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Lower | Upper | |||||||||
| Presence | Intercept | -3.14 | 1.02 | 9.42 | 1.00 | 0.00 | ||||
| Barthel index score | <40 | 2.18 | 1.04 | 4.42 | 1.00 | 0.04 | 8.85 | 1.16 | 67.45 | |
| 41-60 | -0.07 | 1.18 | 0.00 | 1.00 | 0.95 | 0.93 | 0.09 | 9.40 | ||
| 61-99 | -0.04 | 1.25 | 0.00 | 1.00 | 0.97 | 0.96 | 0.08 | 11.12 | ||
| 100 | 0b | 0.00 | ||||||||
The reference category is: none.
This parameter is set to zero because it is redundant.
The distribution of pathogenic microbes of pneumonia of convalescent patients with stroke.
| Pathogenic microbes | Cases | Proportion(%) | Classification of Gram staining | Proportion(%) |
|---|---|---|---|---|
| Pseudomonas aeruginosa | 13 | 18.57 | Gram negative bacteria ( | 54.29 |
| Acinetobacter baumannii | 7 | 10.00 | ||
| Klebsiella pneumoniae | 7 | 10.00 | ||
| Escherichia coli | 2 | 2.86 | ||
| Haemophilus influenzae | 2 | 2.86 | ||
| Enterobacter aerogenes | 1 | 1.43 | ||
| Oligotrophic maltophilia | 1 | 1.43 | ||
| Not clear | 5 | 7.14 | ||
| Staphylococcus aureus | 2 | 2.86 | Gram positive bacteria( | 10.00 |
| Not clear | 5 | 7.14 | ||
| Candida albicans | 3 | 4.29 | Fungus( | 5.71 |
| Candida glabrata | 1 | 1.43 | ||
| Not clear | 21 | 30.00 | Not clear( | 30.00 |
| Total | 70 | 100.00 | 100.00 |
A total of 61 people were diagnosed with pneumonia, 9 of whom had 2 microbial infections by microbial cultivation or it was confirmed that gram-positive bacteria and gram-negative bacteria were infected at the same patient under the microscope, so the total number of pathogenic strains was 70.
Fig 1The drug resistance rate of first three pathogens that isolated from pneumonia patients. (A: Drug resistance rate of Pseudomonas aeruginosa, n=13; B: Drug resistance rate of Acinetobacter baumannii, n=7; C: Drug resistance rate of Klebsiella pneumoniae, n=7. SAZT: Aztreonam; TCC: Ticarcillin/clavulanic acid; MEM: Meropenem; TZP: Piperacillin/tazobactam; LVX: Levofloxacin; GAT: Gatifloxacin; CAZ: Ceftazidime; SCF: Cefoperazone/sulbactam; GEN: Gentamicin; FEP: Cefepime; PRL: Piperacillin; COL: Colistin; AK: Amikacin. SAM: Ampicillin/sulbactam; CRO: Cefatriaxone; SXT: Sulfamethoxazole/Trimethoprim; MNO: Minocycline; TGC: Tegafycline; CXM: Cefuroxime; FOX: Cefoxitin.)